|
US2021062259A1
|
|
COMPOSITIONS AND METHODS FOR AMPLIFICATION AND DETECTION OF HEPATITIS B VIRUS RNA, INCLUDING HBV RNA TRANSCRIBED FROM cccDNA
|
|
US2020208226A1
|
|
Non-replicative transduction particles with one or more non-native tail fibers and transduction particle-based reporter systems
|
|
US2020048682A1
|
|
Methods for performing multiplexed real-time pcr
|
|
US2020017895A1
|
|
Reagents and methods for post-synthetic modification of nucleic acids
|
|
US2019292596A1
|
|
Modified nucleoside phosphates with high thermal stability
|
|
US2019185948A1
|
|
Non-replicative transduction particles and transduction particle-based reporter systems
|
|
US2019178886A1
|
|
Identification of antigen epitopes and immune sequences recognizing the antigens
|
|
US2019161797A1
|
|
Photocleavable nucleotide reagents with high stability
|
|
US2019024155A1
|
|
Methods for performing multiplexed real-time PCR in a self-contained nucleic acid analysis pouch
|
|
US2019024189A1
|
|
Compositions and methods for detection of Babesia
|
|
US2018363044A1
|
|
Compositions and methods for improving the thermal stability of nucleic acid amplification reagents
|
|
US2018370992A1
|
|
Catalysts for reversing formaldehyde adducts and crosslinks
|
|
US2018345274A1
|
|
Modified sample processing device
|
|
US2018345275A1
|
|
Customizable Sample Processing Device
|
|
US2019093155A1
|
|
Multiplex Nucleic Acid Amplification Assay
|
|
US2018339294A1
|
|
Packaging for a molecular diagnostic cartridge
|
|
US2018179600A1
|
|
Systems & methods for detecting cells using engineered transduction particles
|
|
US2019211377A1
|
|
Cobra probes to detect a marker for epidemic ribotypes of clostridium difficile
|
|
US2018179585A1
|
|
Reversibly protected nucleotide reagents with high thermal stability
|
|
US2018129781A1
|
|
Detection of sequence variants
|
